Observational studyAdvances in therapy2025

Risk Factors Associated with Suboptimal Real-World Outcomes in Patients with EGFR-Mutated Non-Small Cell Lung Cancer Treated with Front-Line Recommended Therapy.

Alexander I Spira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.